- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Preeya Noronha Pinto
Event 16 results
Webinar
September 9, 2021
14th Annual King & Spalding Medical Device Summit
Speaking Engagement
March 3, 2021
Preeya Noronha Pinto to Speak on FDLI’s Virtual Introduction to Medical Device Law and Regulation Conference
Speaking Engagement
December 16, 2020
Preeya Noronha Pinto to Speak at Food and Drug Law Institute Conference on Enforcement, Litigation, and Compliance
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Speaking Engagement
April 2, 2020
Preeya Noronha Pinto to Speak at Food and Drug Law Institute’s Conference
Speaking Engagement
November 14, 2019
Preeya Noronha Pinto to Speak at FDLI’s Introduction to Medical Device Law and Regulation Conference
Conference
November 12, 2019
12th Annual King & Spalding Pharmaceutical University
Conference
September 5, 2019
12th Annual Medical Device Summit
Speaking Engagement
November 7, 2018
Preeya Noronha Pinto, Jessica Ringel, Gillian Russell to Speak at Food and Drug Law Institute’s Introduction to Medical Device Law and Regulation Seminar
Conference
June 21, 2018
West Coast Pharmaceutical & Medical Device University
Conference
January 12, 2017
An Introduction to the 21st Century Cures Act
Conference
November 15, 2016
9th Annual King & Spalding Pharmaceutical University